Tokyo INTERPHEX Week and Regenerative Medicine Expo 2026

Tokyo INTERPHEX Week and Regenerative Medicine Expo will be held from May 20–22, 2026 at Makuhari Messe, presenting technologies for pharmaceutical manufacturing, bioprocessing, regenerative medicine, packaging, ingredients, analysis, digital transformation, and contract services. The event gathers 950 exhibitors and 35,000 visitors. Organized by RX Japan Ltd., the exhibition helps attendees source equipment, compare technologies, explore contract development and manufacturing solutions, evaluate digital innovations, and network across Japan’s largest pharma and regenerative medicine marketplace.

Range of Exhibition

• INTERPHEX Week – Plant & Manufacturing Technology:
  Plant engineering equipment, sterilization systems, clean-room technology, process measurement and inspection solutions.
• Pharma Japan – Ingredients & Chemicals:
  APIs, intermediates, functional materials, fine chemicals, analytical tools, and synthesis support products.
• Biopharma Expo – Bioprocess Technology:
  Bioreactors, contract biomanufacturing, separation and purification equipment.
• PharmaLab Expo – Laboratory & R&D Solutions:
  Drug screening devices, analytical and physics instruments, AI drug-discovery solutions.
• Pharma Digital Transformation Expo – Digital/AI Solutions:
  AI drug-discovery platforms, digital transformation tools for manufacturing, digital marketing support for pharma.
• CMO/CDMO Expo – Contract Services:
  API and biopharmaceutical contract manufacturing, packaging and filling services, analysis and testing, formulation development, and specialized contract services.
• Regenerative Medicine Expo – Cell & Regenerative Technology:
  Culture media, reagents, serums, scaffolds, vessels, incubators, analytical devices, cell-quality evaluation, cell banks, CPCs, biomaterials, contract services, transportation, consulting, and licensing.

Target Audience

Pharmaceutical manufacturers, biopharma specialists, R&D teams, laboratory scientists, production engineers, CMOs/CDMOs, quality-control professionals, medical researchers, technology suppliers, and regulatory consultants.